Engineered Protein Inhibitors of SARS-CoV-2 Entry: Difference between revisions

Revision as of 18:33, 22 April 2025 view source Elizabeth Yowell (talk \| contribs) 133 edits No edit summary ← Older edit		Revision as of 18:34, 22 April 2025 view source Elizabeth Yowell (talk \| contribs) 133 edits No edit summary Newer edit →
Line 41:		Line 41:

	Figure 4 shows the sequence comparison between the interacting helix of ACE2 and the helices of the three minibinders. [[Image:Comparison.jpeg\|400 px\|left\|thumb\|Figure 4: The sequence differences between ACE2, AHB2, LCB1 and LCB3.]]		Figure 4 shows the sequence comparison between the interacting helix of ACE2 and the helices of the three minibinders. [[Image:Comparison.jpeg\|400 px\|left\|thumb\|Figure 4: The sequence differences between ACE2, AHB2, LCB1 and LCB3.]]

Navigation menu